Brief: Titan Pharmaceuticals Announces Pricing Of $8.0 Million Underwritten Public Offering
28/10/2020 19:44
Oct 28 (Reuters) - Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS ANNOUNCES PRICING OF $8.0 MILLION
UNDERWRITTEN PUBLIC OFFERING
* TITAN PHARMACEUTICALS - PRICING OF AN UNDERWRITTEN PUBLIC
OFFERING OF 80 MILLION UNITS AT A PRICE OF $0.10 PER UNIT
Source text for Eikon: ID:nPn5lN6YCa
Further company coverage: TTNP.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.